Search
moon
sun

T132. Fluid and electrolyte therapy in infants and children

I. Introduction
1. ์†Œ์•„์—์„œ ์ˆ˜๋ถ„๊ณผ ์ „ํ•ด์งˆ ์ด์ƒ์˜ ๊ฐ€์žฅ ํ”ํ•œ ์›์ธ์€ ํƒˆ์ˆ˜์ด๋‹ค. 2. ํ”ํ•œ ํƒˆ์ˆ˜์˜ ์›์ธ์€ Table 131-1 ์— ์†Œ๊ฐœ๋˜์–ด ์žˆ๊ณ , ํƒˆ์ˆ˜๋กœ ์ธํ•œ ํ”ํ•œ ์ฆ์ƒ์€ Table 131-2์—
์†Œ๊ฐœ๋˜์–ด ์žˆ๋‹ค.
II. Pathophysiology
โ€ข
์œ ์•„์™€ ์†Œ์•„๋Š” ๋ฐœ๋‹ฌํ•™์  ๋ฐ ์ƒ๋ฆฌํ•™์  ์ด์œ ๋กœ ํŠนํžˆ ํƒˆ์ˆ˜์— ์ทจ์•ฝํ•˜๋‹ค. 1. ๋ณดํ˜ธ์ž๊ฐ€ ์ฃผ๋Š” ๊ฒฝ๊ตฌ ์ˆ˜๋ถ„์— ์˜์กดํ•˜๊ฒŒ ๋˜์–ด ์Šค์Šค๋กœ ์„ญ์ทจ๋ฅผ ์กฐ์ ˆํ•  ์ˆ˜ ์—†๋‹ค. 2. ์„ฑ์ธ ๋ฐ ๋‚˜์ด๊ฐ€ ๋งŽ์€ ์†Œ์•„์— ๋น„ํ•ด ์ˆ˜๋ถ„ ์š”๊ตฌ๋Ÿ‰์ด ๋งŽ๊ณ , ์ˆ˜๋ถ„ ์†์‹ค์˜ ์œ„ํ—˜์ด ๋” ํฌ๋‹ค. 3. ๊ธฐ์ดˆ๋Œ€์‚ฌ๋Ÿ‰์ด young children์—์„œ ๊ฐ€์žฅ ๋†’๋‹ค.
12๊ฐœ์›”์—์„œ ์ตœ๊ณ ์ ์— ๋‹ฌํ•˜๊ณ  3์„ธ๋ถ€ํ„ฐ ์ ์ฐจ ๊ฐ์†Œํ•˜๊ธฐ ์‹œ์ž‘ํ•œ๋‹ค. 4. Total body water๊ฐ€ ์œ ์•„์—์„œ๋Š” ์ฒด์ค‘์˜ 75%๋ฅผ ์ฐจ์ง€ํ•˜๊ณ , 1์„ธ๋Š” 60%๊นŒ์ง€ ๊ฐ์†Œํ•˜๋ฉฐ puberty๊นŒ์ง€
์ด ๋น„์œจ์ด ์œ ์ง€๋œ๋‹ค. ์ฒด์ค‘์— ๋น„ํ•ด ์ˆ˜๋ถ„์ด ๋งŽ๊ธฐ ๋•Œ๋ฌธ์— ์ˆ˜๋ถ„ ์†์‹ค์— ๋Œ€์ฒ˜๊ฐ€ ์ทจ์•ฝํ•˜๊ณ , ์†Œ๋ณ€ ๋†์ถ• ๋Šฅ๋ ฅ์ด
๋–จ์–ด์ง„๋‹ค. 5. Young children์—์„œ๋Š” ๋ฐœ์—ด๊ณผ ๊ฐ™์€ hypermetabolic state๊ฐ€ ์ข€ ๋” ํ”ํ•˜๊ธฐ ๋•Œ๋ฌธ์— ์ˆ˜๋ถ„ ์š”๊ตฌ๋Ÿ‰์ด
๋” ๋งŽ๋‹ค. 6. Na+์™€ ์ˆ˜๋ถ„์˜ ๊ฒฝ์šฐ ๊ฐ™์ด ์กฐ์ ˆ๋˜๊ธฐ ๋•Œ๋ฌธ์— ํƒˆ์ˆ˜๋Š” ์ข…์ข… ํ˜ˆ์žฅ Na+ ๋†๋„์— ๋”ฐ๋ผ ๋ถ„๋ฅ˜๋œ๋‹ค.
(1) Hypernatremic (hypertonic) dehydration (Na+ >145mEq/L) : Blood๋ณด๋‹ค ๋‚ฎ์€ Na+์„ ํ•จ์œ ํ•œ fluid ์†์‹ค
(2) Isonatremic (isotonic) dehydation (Na+ : 135~145mEq/L) : ๊ฐ€์žฅ ํ”ํ•œ ํƒˆ์ˆ˜์˜ ํ˜•ํƒœ
(3) Hyponatremic (hypotonic) dehydration (Na+ <135mEq/L) : Blood๋ณด๋‹ค ๋†’์€ Na+์„ ํ•จ์œ ํ•œ fluid ์†์‹ค
III. Clinical features
1. History
(1) ์ ์ ˆํ•œ ๋ณ‘๋ ฅ์ฒญ์ทจ๋ฅผ ํ†ตํ•ด ํ™˜์•„์˜ fluid or electrolyte disorder๋ฅผ ์˜์‹ฌํ•  ์ˆ˜ ์žˆ๋‹ค. (2) ์–ด๋– ํ•œ ์ฆ์ƒ์ด ์–ธ์ œ, ์–ด๋–ค ์ƒํ™ฉ(ex. ๋”์šด ํ™˜๊ฒฝ)์—์„œ ๋ฐœ์ƒํ–ˆ๋Š”์ง€, ๋ฐœ์—ด, ๋นˆํ˜ธํก ์ฆ์ƒ ์œ ๋ฌด์™€ ์‚ฌ์ „์—
์–ด๋–ค ์น˜๋ฃŒ๋ฅผ ๋ฐ›์•˜๋Š”์ง€ ํ™•์ธํ•œ๋‹ค. (3) ํ™˜์•„๊ฐ€ ์–ด๋–ค ๊ฒƒ์„ ์ถฉ๋ถ„ํžˆ, ์ž์ฃผ ์„ญ์ทจํ–ˆ๋Š”์ง€ ํ‰๊ฐ€ํ•œ๋‹ค.
(Water, hypotonic solution โ†’ Hyponatremia์˜ ์œ„ํ—˜์„ฑ์„ ๋†’์ž„) (4) ๊ตฌํ† , ์„ค์‚ฌ, ์†Œ๋ณ€๋Ÿ‰, ๋ฐœํ•œ, ์‹ ์ฒด์ง„์ฐฐ, ์˜์‹์ˆ˜์ค€ ๋“ฑ์„ ํ†ตํ•ด volume status๋ฅผ ํ‰๊ฐ€ํ•œ๋‹ค. (5) ๊ฐ์—ผ์˜ ์ง•ํ›„, ์—ฌํ–‰๋ ฅ, ๋ณ‘์ž์™€์˜ ์ ‘์ด‰ ์œ ๋ฌด, ๊ธฐ์ €์งˆํ™˜, ๋…์„ฑ๋ฌผ์งˆ์˜ ์„ญ์ทจ ์—ฌ๋ถ€๋ฅผ ํ™•์ธํ•˜๋Š” ๊ฒƒ๋„
๋„์›€์ด ๋œ๋‹ค.
(6) ์•Œ ์ˆ˜ ์žˆ๋‹ค๋ฉด ๋ชธ๋ฌด๊ฒŒ์˜ ๋ณ€ํ™”๊ฐ€ ๊ฐ€์žฅ ์ค‘์š”ํ•˜๋‹ค. โ†’ Volume state ํ‰๊ฐ€์˜ gold standard์ด๋‹ค.
2. Physical examination
โ€ข
Table 132-2์— ํƒˆ์ˆ˜์˜ ํ”ํ•œ ์ฆ์ƒ ๋ฐ ์ฆํ›„๊ฐ€ ๋‚˜์™€ ์žˆ๋‹ค. * Table 131-6์—๋Š” ํƒˆ์ˆ˜์— ๋Œ€ํ•œ ๊ฐ„๋‹จํ•œ scoring system์ด ๋‚˜์™€ ์žˆ๋‹ค.
(1) Tachycardia and tachypnea 1 ๋ณด์ƒ์„ฑ ์‡ผํฌ์—์„œ๋Š” ํ˜ˆ์••์ด ์ •์ƒ์ผ ์ˆ˜ ์žˆ์œผ๋‚˜ ๋น„๋ณด์ƒ์„ฑ ์‡ผํฌ์—์„œ๋Š” ํ˜ˆ์•• ์ €ํ•˜๊ฐ€ ๋™๋ฐ˜๋  ์ˆ˜ ์žˆ๋‹ค. 2 ํ˜ธํก์ˆ˜์˜ ์ฆ๊ฐ€๋Š” ์ค‘๋“ฑ๋„, ์ค‘์ฆ ํƒˆ์ˆ˜์—์„œ ๋Œ€์‚ฌ์„ฑ ์‚ฐ์ฆ์˜ ์ง„ํ–‰์œผ๋กœ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค.
(2) Mental status change, lethargy, hypotonia : ์‹ฌ๊ฐํ•œ ํƒˆ์ˆ˜๋‚˜ ์ „ํ•ด์งˆ ์ด์ƒ์„ ์˜๋ฏธํ•œ๋‹ค. (3) Etc.
1 ์œ ์•„์—์„œ๋Š” fontanelle์˜ ํ™•์ธ (Flat or sunken) 3 ์ž…์ˆ ์˜ ๋งˆ๋ฅธ ์ •๋„ 5 ํ”ผ๋ถ€์˜ ์˜จ๋„๋‚˜ ์ƒ‰ ๋ฐ ํƒ„์„ฑ
2 ๋ˆˆ๋ฌผ์˜ ์œ ๋ฌด 4 ์นจ ๋ถ„๋น„ ์ €ํ•˜ 6 Capillary refill time ๋“ฑ.
3. Laboratory evaluation (1) ํƒˆ์ˆ˜ ์ •๋„์˜ ํ‰๊ฐ€๋ฅผ ์œ„ํ•œ ๊ธฐ๋ณธ์ ์ธ ํ”ผ๊ฒ€์‚ฌ๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ํ•„์š”ํ•˜์ง€ ์•Š๋‹ค. (2) ๋งŽ์€ ์—ฐ๊ตฌ์—์„œ ํ”ผ๊ฒ€์‚ฌ์™€ ํƒˆ์ˆ˜์˜ ์ค‘์ฆ๋„์™€๋Š” ํฐ ๊ด€๊ณ„๊ฐ€ ์—†๋‹ค๊ณ  ๋‚˜์™”๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. (3) ์ˆ˜์•ก ํˆฌ์—ฌ๋ฅผ ์œ„ํ•ด ์ •๋งฅ์„ ํ™•๋ณดํ•˜๊ฑฐ๋‚˜ ์ „ํ•ด์งˆ ์ด์ƒ์˜ ์ฆํ›„๊ฐ€ ์žˆ๋Š” ๊ฒฝ์šฐ, DKA์™€ ๊ฐ™์€ ์ด์ƒ์ด ์˜ˆ์ธก๋˜๋Š”
๊ฒฝ์šฐ ํ˜ˆ์žฅ ์ „ํ•ด์งˆ ๋†๋„๋ฅผ ์ธก์ •ํ•ด์•ผ ํ•œ๋‹ค.
(4) ์†Œ์•„์—์„œ ์˜์‹ ์ €ํ•˜๊ฐ€ ๋ณด์ด๋Š” ๊ฒฝ์šฐ BST๋ฅผ ์ธก์ •ํ•˜๊ณ  ์ €ํ˜ˆ๋‹น์„ ๋น ๋ฅด๊ฒŒ ๊ต์ •ํ•ด์•ผ ํ•œ๋‹ค.
IV. Initial treatment of dehydration
โ€ข
์ˆ˜๋ถ„ ๋ณด์ถฉ์€ 3๊ฐ€์ง€ ๋ฐฉ๋ฒ•์œผ๋กœ ์‹œํ–‰ํ•œ๋‹ค. 1. Oral / 2. Nasogastric / 3. Parentral * ํƒˆ์ˆ˜ ์ •๋„์— ๋”ฐ๋ฅธ ์ˆ˜์•ก ์š”๋ฒ•์€ Table 132-3 ์— ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค.
1.
Mild to moderate dehydration (1) ๊ฒฝ์ฆ, ์ค‘๋“ฑ๋„์˜ ํƒˆ์ˆ˜๋Š” ๊ฒฝ๊ตฌ ํ˜น์€ ๋น„์œ„๊ด€์„ ํ†ตํ•œ ์ˆ˜์•ก ํˆฌ์—ฌ๋กœ ํšŒ๋ณต ๊ฐ€๋Šฅํ•˜๋‹ค. (2) ๊ตฌํ†  ํ™˜์ž์—์„œ IV ์ˆ˜์•ก ๋ณด์ถฉ๊ณผ NG tube ํ†ตํ•œ hydration์— ๋Œ€ํ•œ ์—ฐ๊ตฌ์—์„œ NG tube๋ฅผ ํ†ตํ•œ ์ˆ˜๋ถ„ ๊ณต๊ธ‰์ด ๋ถ€์ž‘์šฉ์ด ๋” ์ ๊ณ , ์ผ€ํ†ค๋‡จ์—์„œ์˜ ํšŒ๋ณต์ด ๋น ๋ฅด๋‹ค๊ณ  ํ•œ๋‹ค.
2. Moderate and severe dehydation
(1) ํ™˜์•„๊ฐ€ ๊ฒฝ๊ตฌ๋‚˜ ๋น„์œ„๊ด€์„ ํ†ตํ•œ ์ˆ˜์•ก ํˆฌ์—ฌ๊ฐ€ ์–ด๋ ค์šด ๊ฒฝ์šฐ ํ˜น์€ ์ค‘์ฆ ํƒˆ์ˆ˜๋Š” ์งง์€ ์‹œ๊ฐ„ ์•ˆ์— ๋‹ค๋Ÿ‰์˜ ์ฆ‰๊ฐ์ ์ธ ์ˆ˜์•ก ํˆฌ์—ฌ๊ฐ€ ํ•„์š”ํ•˜๋‹ค. ์ด์— ๋Œ€ํ•ด์„œ๋Š” Table 132-4์— ์ •๋ฆฌ๋˜์–ด ์žˆ๋‹ค.
(2) ์‹ฌํ•œ ํƒˆ์ˆ˜ (Severe with uncompensated shock) 1 ์ดˆ๊ธฐ์— 20ml/kg์˜ isotonic solution(0.9 NS, lactated Ringer's)์„ 5๋ถ„์—์„œ 10๋ถ„ ๊ฐ„๊ฒฉ์œผ๋กœ bolus
ํˆฌ์—ฌํ•˜๋ฉฐ, ํ˜ˆ์—ญํ•™์ ์œผ๋กœ ์•ˆ์ •์ด ๋  ๋•Œ๊นŒ์ง€ ๋ฐ˜๋ณตํ•œ๋‹ค. 2 ๊ธˆ๊ธฐ๊ฐ€ ๋˜๋Š” ๊ธฐ์ €์งˆํ™˜์ด ์—†๋Š” ๊ฒฝ์šฐ ์ฒซ ํ•œ ์‹œ๊ฐ„ ๋‚ด์— 60ml/kg ์ด์ƒ์ด ํ•„์š”ํ•  ์ˆ˜๋„ ์žˆ๋‹ค.
(3) ์‡ผํฌ๋ฅผ ๋™๋ฐ˜ํ•˜์ง€ ์•Š์€ ์ค‘๋“ฑ๋„์˜ ํƒˆ์ˆ˜ (Moderate to severe without signs of shock) 1 20ml/kg์˜ ์ˆ˜์•ก์„ ํ•œ ์‹œ๊ฐ„ ๋™์•ˆ bolus๋กœ ์ค€๋‹ค. 2 kg๋‹น 50 to 60ml์˜ ์ˆ˜์•ก์„ 1์‹œ๊ฐ„ ๋™์•ˆ ๊ณต๊ธ‰ํ•˜๋Š” rapid or ultrarapid ๋ฐฉ๋ฒ•์€ 20ml/kg over 1hr๋กœ
ํˆฌ์•ฝํ•˜๋Š” ๊ธฐ๋ณธ์ ์ธ ๋ฐฉ๋ฒ•์— ๋น„ํ•ด ๋ณ‘์› ์ž…์› ๊ธฐ๊ฐ„์ด ๊ธธ๊ณ , ์•„ํ”„๋ฆฌ์นด์—์„œ ์‹œํ–‰ํ•œ ์—ฐ๊ตฌ์—์„œ๋Š” ์‚ฌ๋ง๋ฅ ์ด ๋” ๋†’์•˜๋‹ค.
V. Maintenance treatment
1. The primary formula for daily fluid requirements is calculated as follows (1) For the first 10kg : 100ml/kg/d (4ml/kg/h) (2) For the second 10kg : 50ml/kg/d (2ml/kg/h) (3) For each kg>20kg : 20ml/kg/d (1ml/kg/h)
โ€ข
Na+ : 2 to 3mEq/kg/d * K+ : 2 mEq/kg/d
For example : 10-kg baby requires : 100mL ร— 10kg, or a total of 1000 mL/d. 20-kg child requires : (100mL ร— 10kg) + (50mL ร—10kg) = 1500mL/d. 40-kg child requires : (100mL ร— 10kg) + (50mLร—10kg) + (20mLร—20kg) = 1900mL/d.
2. HypoNa๋Š” IV ์ˆ˜์•ก ์น˜๋ฃŒ์—์„œ ๊ฐ€์žฅ ํ”ํ•œ ์ธ์œ„์  ํ•ฉ๋ณ‘์ฆ์ด๊ธฐ ๋•Œ๋ฌธ์— ์œ ์ง€ ์ˆ˜์•ก์œผ๋กœ๋Š” isotonic fluid๋ฅผ ์‚ฌ์šฉํ•˜๋Š” ๊ฒƒ์ด ์ค‘์š”ํ•˜๋‹ค. ์˜ˆ๋ฅผ ๋“ค์ž๋ฉด normal saline with 5% dexrose (5DS)
VI. Disorders of sodium
1. Hyponatremia (Na+ < 135mEq/L) (1) Osmolarity (275~290mOsm/kg, ์ •์ƒ) ํ™•์ธ : pseudo-hyponatremia ๊ฐ๋ณ„ (2) ์ฃผ์š” ์›์ธ : GI losses and water intoxication (Hypotonic repalcement fluids) (3) Sx.์€ acuteํ•˜๊ฒŒ 120mEq/L ์•„๋ž˜๋กœ ๋–จ์–ด์งˆ ๋•Œ์— ์ฃผ๋กœ ๋ฐœ์ƒ
1 ์‹ ๊ฒฝ๊ณ„ ์ฆ์ƒ(N/V, HA, mental change, seizure ๋“ฑ) 2 ๊ทผ์œก๊ณ„ํ†ต ์ฆ์ƒ(weakness, muscle cramps, lethargy)
(4) ์น˜๋ฃŒ (Table 132-6)
โ€ข
Sodium level์ด ๋น ๋ฅด๊ฒŒ ๊ต์ •๋˜๋Š” ๊ฒƒ์„ ์ฃผ์˜ํ•ด์•ผ ํ•œ๋‹ค.
1 ์‹ฌ๊ฐํ•œ ์‹ ๊ฒฝํ•™์  ์ฆ์ƒ(ํ˜ผ๋ˆ, ์˜์‹ ์žฅ์• ๋‚˜ ๊ฒฝ๋ จ ๋“ฑ)์€ ์ฃผ๋กœ Na+<120mmol/L์—์„œ ๋ฐœ์ƒํ•˜๋ฉฐ, ์ด๋Ÿฌํ•œ ๊ฒฝ์šฐ ์‹ ๊ฒฝํ•™์  ์ฆ์ƒ์ด ํ˜ธ์ „๋  ๋•Œ๊นŒ์ง€ ๋น ๋ฅด๊ฒŒ ๊ต์ •ํ•˜๊ฑฐ๋‚˜, Na+ level์ด 120mmol/L์— ๋„๋‹ฌํ•˜๊ฒŒ ๊ต์ •ํ•œ๋‹ค.
2. Hypernatremia (Na+ > 145mEq/L) (1) ์ฃผ์š” ์›์ธ
1 ํƒˆ์ˆ˜(GI or renal loss, insensible loss, ๊ฐ€์žฅ ํ”ํ•œ ์›์ธ์€ diarrhea)
2 ๊ฐ„ํ˜น sodium์˜ ๊ณผ๋‹ค ์„ญ์ทจ (2) Na+>160mEq/L์ด๋ฉด permanent neurologic sequelae๊ฐ€ ์ƒ๊ธธ ์ˆ˜ ์žˆ์œผ๋ฏ€๋กœ ์ฃผ์˜ํ•ด์•ผ ํ•จ! (3) ์ฆ์ƒ : ์˜์‹๋ณ€ํ™”, ์œ„์•ฝ๊ฐ, ์šด๋™์‹ค์กฐ, ๊ณผ๋‹ค๋ฐ˜์‚ฌ์ฆ, ๊ฒฝ๋ จ, ICH, ํ˜ผ์ˆ˜, ์‚ฌ๋ง ๋“ฑ (4) ์น˜๋ฃŒ (Table 132-7)
โ€ข
Sodium level์„ ์ ์ง„์ ์œผ๋กœ ๊ต์ •ํ•˜์—ฌ, brain edema๋‚˜ central pontine myelinolysis์„ ์˜ˆ๋ฐฉํ•œ๋‹ค.
VII. Disorder of potassium
1. Hypokalemia (K+<3.4mEq/L) (1) ์ฃผ์š” ์›์ธ : ๋งŽ์€ ์–‘์˜ ๊ตฌํ† , ์„ค์‚ฌ (๊ทธ ์™ธ์—๋„ loop diuretics, DKA ๋“ฑ์ด ์žˆ๋‹ค.) (2) Sx. : muscle weakness, ileus, cardiac conduction disturbances (3) ์น˜๋ฃŒ
1 ๋Œ€๋ถ€๋ถ„ ๊ฒฝ๊ตฌํˆฌ์—ฌ (2 to 5mEq/kg/d divided bid or tid, maximum: 40mEq/dose) IV therapy๊ฐ€ ํ•„์š”์‹œ์—๋Š” 0.2 to 0.3mEq/kg/h
2 ์‘๊ธ‰์ƒํ™ฉ(HypoK induced resp. insufficiency, cardiac manifestations) : 0.5mEq/kg/h with ECG mornitoring : ๋†๋„๊ฐ€ 60mEq/L๋ฅผ ๋„˜๋Š” ๊ฒฝ์šฐ ํ˜ˆ๊ด€ํ†ต์„ ์œ ๋ฐœํ•˜๋ฏ€๋กœ C-line์„ ํ†ตํ•ด ์ฃผ์ž…ํ•ด์•ผ ํ•œ๋‹ค.
2. Hyperkalemia (K+>5.5mEq/L) (1) ์ฃผ์š” ์›์ธ
1 ํ˜ˆ์•ก์„ ์ฑ„์ทจํ•˜๋Š” ์ค‘์— ์ƒ๊ธด ์šฉํ˜ˆ (Most common) 3 ํšก๋ฌธ๊ทผ์œตํ•ด์ฆ 5 ์—ด์‚ฌ๋ณ‘ 7 ์ข…์–‘์œตํ•ด์ฆํ›„๊ตฐ
9 Adrenal corticoid insufficiency (2) Sx.
2 ์‹ ๊ธฐ๋Šฅ ์žฅ์•  4 ํ™”์ƒ 6 ์™ธ์ƒ 8 Hemolytic anemia, 10 K+ sparing diuretics
1 Cardiac conduction delay : Tall T wave โ†’ PR interval ์ฆ๊ฐ€ โ†’ QRS widening โ†’ Sine wave
(3) ์น˜๋ฃŒ (Table 132-8)
VIII. Disorder of calcium, magnesium
1. Hypocalcemia (Ca2+ < 8mg/dL(2mmol/L) or iCa2+ < 4.4mg/dL(1.1mmol/L)) (1) ์ฃผ์š” ์›์ธ : ์šฐ์œ  ์ˆ˜์œ ํ•˜๋Š” ์•„์ด (Phosphate๊ฐ€ ๋†’์•„์„œ Ca2+ ๊ฐ์†Œ์œ ๋ฐœ), CRF, ๊ณผํ˜ธํก
1 Hypoparathyroidism : Idiopathic, ๊ฐ‘์ƒ์„  ์ˆ˜์ˆ  ํ›„, Mg ๊ฒฐํ•๊ณผ ์—ฐ๊ด€
2 End-organ resistance to parathyroid hormone : Vit. D ๊ฒฐํ•๊ณผ ์—ฐ๊ด€ (2) ์น˜๋ฃŒ (์ฆ์ƒ ์žˆ์„ ๋•Œ๋งŒ) : Calcium gluconate 10% 100mg/kg (100mg/min ๋ฏธ๋งŒ์˜ ์†๋„๋กœ)
2. Hypercalcemia (Ca2+ > 11mg/dL) (1) ์ฃผ์š” ์›์ธ : Lymphoreticular system์„ ์นจ๋ฒ”ํ•˜๋Š” malignancy (2) ์น˜๋ฃŒ : ๊ธ‰์„ฑ๊ธฐ์—์„œ๋Š” aggressive IV hydration๋ถ€ํ„ฐ ์‹œํ–‰ (Maintenance์˜ ๋‘ ๋ฐฐ)
3. Hypomagnesemia (Mg2+ < 1.5mEq/L) (1) ์ฃผ์š” ์›์ธ : GI or renal losses, hypercalcemia, hypophosphatemia (2) Sx. : hypocalcemia ์ฆ์ƒ๊ณผ ์œ ์‚ฌ, Torsades de pointes (3) ์น˜๋ฃŒ (๊ฒฝ๋ จ, ๋ถ€์ •๋งฅ ๋ฐœ์ƒ์‹œ) : 10% MgSO4 25~50mg/kg
4. Hypermagnesemia (Mg2+ > 2.2mEq/L) (1) ์ฃผ์š” ์›์ธ : Exogenous ingestion (์ œ์‚ฐ์ œ, ๋ณ€๋น„์•ฝ) (2) ์น˜๋ฃŒ(์ฆ์ƒ ์žˆ์„ ์‹œ์—) : Hydration, Ca gluconate 0.5ml/kg IV, Dialysis (CKD ๊ฒฝ์šฐ์—๋Š”)